Table A2a. Categories of adverse events (AEs).

		Placebo (n=40)	0.8 g LT-02 (n=40)	1.6 g LT-02 (n=41)	3.2 g LT-02 (n=35)
Any pretreatment AE	n (%)	5 (12.5%)	6 (15.0%)	8 (19.5%)	3 (8.6%)
Any treatment-emergent AE	n (%)	22 (55.0%)	25 (62.5%)	20 (48.8%)	17 (48.6%)
Any posttreatment AE	n (%)	7 (17.5%)	8 (20.0%)	7 (17.1%)	6 (17.1%)
Any adverse drug reaction (ADR)	n (%)	6 (15.0%)	5 (12.5%)	3 (7.3%)	4 (11.4%)
Any serious adverse event (SAE)	n (%)	4 (10.0%)	5 (12.5%)	2 (4.9%)	1 (2.9%)
Any treatment-emergent SAE	n (%)	4 (10.0%)	4 (10.0%)	2 (4.9%)	0
Any potentially study medication-induced SAE	n (%)	1 (2.5%)	0	0	0